ClinConnect ClinConnect Logo
Search / Trial NCT06683274

Bascom Cleft Lift for Primary Wound Healing in Complex and Recurrent Sacrococcygeal Pilonidal Sinus Disease

Launched by ALBERT SCHWEITZER ZIEKENHUIS, NETHERLANDS · Nov 8, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pilonidal Sinus Bascom Cleft Lift

ClinConnect Summary

This clinical trial is studying a new approach to treating complex or recurring pilonidal sinus disease, which is a painful condition that can occur near the tailbone. The researchers want to find out if a specific surgical method called the cleft lift, when combined with a best practice care plan, helps patients heal faster and return to their normal activities sooner than the usual treatment that uses traditional excision techniques.

To participate in this study, you need to be 16 years or older and have been experiencing symptoms of complex or recurring pilonidal sinus disease. You must also be planning to have surgery and be able to give your consent. This trial is currently recruiting participants, and it welcomes individuals of any gender. If you join, you can expect to receive care based on the new pathway, which aims to improve your healing process. It’s important to note that pregnant individuals or those who cannot understand Dutch sufficiently will not be able to take part in the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 16 years of age and older
  • Symptomatic complex or recurrent pilonidal sinus disease
  • Planned for surgical treatment
  • Signed informed consent
  • Exclusion Criteria:
  • Pregnant
  • Insufficient understanding of the Dutch language or otherwise unable to give consent

About Albert Schweitzer Ziekenhuis, Netherlands

Albert Schweitzer Ziekenhuis, located in the Netherlands, is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. With a strong emphasis on patient-centered care, the hospital integrates innovative practices and cutting-edge technology in its clinical trials. The institution fosters collaboration among multidisciplinary teams, aiming to enhance treatment outcomes and contribute significantly to medical knowledge. Committed to ethical standards and regulatory compliance, Albert Schweitzer Ziekenhuis plays a pivotal role in developing new therapies and improving healthcare delivery within the community and beyond.

Locations

Dordrecht, , Netherlands

Patients applied

0 patients applied

Trial Officials

Robert Smeenk, MD, PhD

Principal Investigator

Albert Schweitzer Ziekenhuis, Netherlands

Boudewijn Toorenvliet, MD, PhD

Principal Investigator

Ikazia ziekenhuis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported